NLRX1 and Ito hypomelanosis: This study identifies the importance of host Nlrx1 during IPA for two contrasting yet clinically relevant isolates of A. fumigatus. We imagine Nlrx1 as a viable therapeutic target for invasive fungal infections given its role in modulating immune signaling and defense in responses to A. fumigatus in two distinct cell populations.